Back

Latest Forum Topics / EFH Ltd    Last:0.044    -0.002

Post Reply

BIO PHARMA company do research on MEDICAL DISEASES Post Reply Rate topic
michaeltan Master	15-Jul-2020 15:50        michaeltan About Contact  Quote this Post! Style: Fundamental   Mood:
x 0   x 0  Alert Admin	Singapore-listed Biolidics signs 5-year deal for use of A*Star technology to develop new Covid-19 test kits.. On its deal with the A*Star arm, Biolidics said most commercially available serology tests against Covid-19, including Biolidics' own Covid-19 antibody test kit launched on March 30, detects IgG and IgM antibodies, which are a group of antibodies produced by the body in response to a novel coronavirus infection. As such, these serology tests are currently used only as an assistive tool in the detection of Covid-19, and are not able to detect specific antibodies that bind to the novel coronavirus and interfere with its ability to infect target cells, Biolidics said. Hope this new developement is deemed to be positive to fight against covid19. newbieliu      ( Date: 15-Jul-2020 15:36) Posted: I am not sure about Temasek.... u can always check from their annual report their major shareholders... Laurenpanna      ( Date: 15-Jul-2020 15:20) Posted: Wow i didn' t know ! How can i find out on this
Useful To Me  Not Useful To Me
alvinlsm Veteran	15-Jul-2020 15:47        alvinlsm About Contact  Quote this Post!
x 0   x 0  Alert Admin	Go to SGX , under their profile there is tab ( ownership ) . Temasek is having 10% of their share . newbieliu      ( Date: 15-Jul-2020 15:36) Posted: I am not sure about Temasek.... u can always check from their annual report their major shareholders... Laurenpanna      ( Date: 15-Jul-2020 15:20) Posted: Wow i didn' t know ! How can i find out on this
Useful To Me  Not Useful To Me
newbie888 Veteran	15-Jul-2020 15:47        newbie888 About Contact  Quote this Post!
x 0   x 0  Alert Admin	I guess the more prominent and reliable ssh is Seeds Capital.. newbieliu      ( Date: 15-Jul-2020 15:36) Posted: I am not sure about Temasek.... u can always check from their annual report their major shareholders... Laurenpanna      ( Date: 15-Jul-2020 15:20) Posted: Wow i didn' t know ! How can i find out on this
Useful To Me  Not Useful To Me
Luke1923 Senior	15-Jul-2020 15:40        Luke1923 About Contact  Quote this Post! Style: Combined   Mood: Yells: "The Lord is my Shepherd; I shall not want."
x 0   x 0  Alert Admin	SGX is always asking for the sake of asking... newbie888      ( Date: 15-Jul-2020 15:37) Posted: Hopefully biolidic is able to answer all these queries by sgx.. Luke1923      ( Date: 15-Jul-2020 14:39) Posted: 1) It was mentioned in the Announcement that the Company had, on 9 July 2020, entered into a licensing agreement (the " Agreement" ) with Accelerate Technologies Pte Ltd (A*ccelerate) for a duration of five years from the date of the Agreement (the Term). Did the Company provide any consideration or outlay for being granted the non-exclusive worldwide rights to use the Technology for the detection of COVID-19 viral spike/Angiotensin Converting Enzyme 2 ( ACES ) blocking antibodies? 2) What are the rights assignment for the products or technologies that are subsequently developed by the Company using the Technology? Are there any differences between how these rights are assigned during the Term and after the Term? Does Biolidics have exclusive rights to the said products or technologies?  3) It is stated in the Announcement that the Company will further develop the Technology .  (a) What is the current status and the Company' s ability with regards to its efforts to further develop the Technology ?  (b) At present, what is the projected timeline or milestone, if any, for Biolidics to successfully develop the Technology?  (c) Are there any conditions that need to be met, such as the completion of the Technology development by the Company, before it could market the serology tests which incorporate the Technology into its Covid-19 Antibody Test Kit or into any other form of serology tests? (d) When does the Company expect to be able to market the serology tests which incorporate the Technology into its Covid-19 Antibody Test Kit or into any other form of serology tests? 4) At present, how far along is Biolidics in successfully incorporating the Technology into its Covid-19 Antibody Test Kit, or into any other form of serology tests? 5) The Agreement with A*ccelerate was entered into on 9 July 2020. We note that the Company called for trading halt on 13 July 2020, at 12:19pm, and released the Announcement on 14 July 2020, 10:46pm.  (a) What are the reasons for the delay in the announcement .  (b) Was the Sponsor aware and consulted on the disclosure of this matter and what was their advice.  (c) When did the Board and Sponsor approve the announcement?
Useful To Me  Not Useful To Me
newbie888 Veteran	15-Jul-2020 15:37        newbie888 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Hopefully biolidic is able to answer all these queries by sgx.. Luke1923      ( Date: 15-Jul-2020 14:39) Posted: 1) It was mentioned in the Announcement that the Company had, on 9 July 2020, entered into a licensing agreement (the " Agreement" ) with Accelerate Technologies Pte Ltd (A*ccelerate) for a duration of five years from the date of the Agreement (the Term). Did the Company provide any consideration or outlay for being granted the non-exclusive worldwide rights to use the Technology for the detection of COVID-19 viral spike/Angiotensin Converting Enzyme 2 ( ACES ) blocking antibodies? 2) What are the rights assignment for the products or technologies that are subsequently developed by the Company using the Technology? Are there any differences between how these rights are assigned during the Term and after the Term? Does Biolidics have exclusive rights to the said products or technologies?  3) It is stated in the Announcement that the Company will further develop the Technology .  (a) What is the current status and the Company' s ability with regards to its efforts to further develop the Technology ?  (b) At present, what is the projected timeline or milestone, if any, for Biolidics to successfully develop the Technology?  (c) Are there any conditions that need to be met, such as the completion of the Technology development by the Company, before it could market the serology tests which incorporate the Technology into its Covid-19 Antibody Test Kit or into any other form of serology tests? (d) When does the Company expect to be able to market the serology tests which incorporate the Technology into its Covid-19 Antibody Test Kit or into any other form of serology tests? 4) At present, how far along is Biolidics in successfully incorporating the Technology into its Covid-19 Antibody Test Kit, or into any other form of serology tests? 5) The Agreement with A*ccelerate was entered into on 9 July 2020. We note that the Company called for trading halt on 13 July 2020, at 12:19pm, and released the Announcement on 14 July 2020, 10:46pm.  (a) What are the reasons for the delay in the announcement .  (b) Was the Sponsor aware and consulted on the disclosure of this matter and what was their advice.  (c) When did the Board and Sponsor approve the announcement?
Useful To Me  Not Useful To Me
newbieliu Elite	15-Jul-2020 15:36        newbieliu About Contact  Quote this Post!
x 0   x 0  Alert Admin	I am not sure about Temasek.... u can always check from their annual report their major shareholders... Laurenpanna      ( Date: 15-Jul-2020 15:20) Posted: Wow i didn' t know ! How can i find out on this ? alvinlsm      ( Date: 15-Jul-2020 15:19) Posted: Temasek and mitsubitshi are the share holders of Biolidic. This counter should be promising .
Useful To Me  Not Useful To Me
Sgvale Supreme	15-Jul-2020 15:35        Sgvale About Contact  Quote this Post!
x 0   x 0  Alert Admin	I know Mitsubishi inside. Temasek also meh? Though Temasek only invest in Blue Chips & potential starters like Grab, Go Jek. If inside ....Bio must be something alvinlsm      ( Date: 15-Jul-2020 15:19) Posted: Temasek and mitsubitshi are the share holders of Biolidic. This counter should be promising .
Useful To Me  Not Useful To Me
Laurenpanna Veteran	15-Jul-2020 15:20        Laurenpanna About Contact  Quote this Post!
x 0   x 0  Alert Admin	Wow i didn' t know ! How can i find out on this ? alvinlsm      ( Date: 15-Jul-2020 15:19) Posted: Temasek and mitsubitshi are the share holders of Biolidic. This counter should be promising .
Useful To Me  Not Useful To Me
michaeltan Master	15-Jul-2020 15:19        michaeltan About Contact  Quote this Post! Style: Fundamental   Mood:
x 0   x 0  Alert Admin	Coronavirus cases soar in USA It&rsquo s not just Florida, Arizona and Texas anymore. States including Oklahoma and Nevada are reporting record numbers of new coronavirus cases, hospitalizations and deaths, according to  data tracked by The Washington Post. More than 62,000 new infections were reported nationwide on Tuesday, pushing the total count since the pandemic began past 3.41 million. ST3-trading      ( Date: 15-Jul-2020 15:05) Posted: wait lo .Sure have some more announcement since is only the beginning..
Useful To Me  Not Useful To Me
alvinlsm Veteran	15-Jul-2020 15:19        alvinlsm About Contact  Quote this Post!
x 0   x 0  Alert Admin	Temasek and mitsubitshi are the share holders of Biolidic. This counter should be promising .
Useful To Me  Not Useful To Me
Superfast Supreme	15-Jul-2020 15:18        Superfast About Contact  Quote this Post!
x 0   x 0  Alert Admin	HV faith... When u enter...
Useful To Me  Not Useful To Me
polarinda Master	15-Jul-2020 15:15        polarinda About Contact  Quote this Post!
x 1   x 0  Alert Admin	Speculation is part of the game la. Nobody force u to long or short ma.
Useful To Me  Not Useful To Me
nott1965 Veteran	15-Jul-2020 15:12        nott1965 About Contact  Quote this Post!
x 0   x 0  Alert Admin	I fully agreed. I had been caught previously during the dot.co era where comapnies like Goldtron and iOne will periodically announce trading halt to stir the market, then announce some funny tie ups with no concrete plans nor figures. In the end when paper can' t cover fire anymore, all bankrupt. Learned my hard lessons as a novice investor then wolverine23      ( Date: 15-Jul-2020 14:26) Posted: Don't assume one is right unless proven. Anything can happen! WL123456      ( Date: 15-Jul-2020 14:04) Posted: It?s a pity that people don?t learn their lesson. What you post if very useful but still people don?t look at fundamentals and wants to join in the pump and dump. They didn?t realise that this company has been releasing such info periodically just to ramp up the share price but in the end, the company still record losses. However I applaud your ethics in reaching out to those newbies who would have otherwise be caught in the euphoria
Useful To Me  Not Useful To Me
ST3-trading Senior	15-Jul-2020 15:05        ST3-trading About Contact  Quote this Post!
x 0   x 0  Alert Admin	wait lo .Sure have some more announcement since is only the beginning..
Useful To Me  Not Useful To Me
chanbs Elite	15-Jul-2020 14:48        chanbs About Contact  Quote this Post!
x 0   x 0  Alert Admin	Similar to Medtech. Unable to volume is not there SgYuan      ( Date: 15-Jul-2020 11:28) Posted: Now becareful 1h conversion line resistance 495 - if cannot punch up then very bad 1h baseline support 440 1h mid bollinger support 425 day chart cloud support 420 if support break wave c continue
Useful To Me  Not Useful To Me
Sgvale Supreme	15-Jul-2020 14:43        Sgvale About Contact  Quote this Post!
x 0   x 0  Alert Admin	Yes Bro.. ST3-trading      ( Date: 15-Jul-2020 14:42) Posted: anyway is A star - gov de. I believe A start no time to do listing in sgx, too troublesome, so they come to bio they need to push their invention to the world . Hopefullly Next time is vaccine from them US will confrim push the vaccine out , bcos trump want to be re-elected . But how welll is this vaccine , duuno . SG gov wun use to us until is totally proven .
Useful To Me  Not Useful To Me
ST3-trading Senior	15-Jul-2020 14:42        ST3-trading About Contact  Quote this Post!
x 0   x 0  Alert Admin	anyway is A star - gov de. I believe A start no time to do listing in sgx, too troublesome, so they come to bio they need to push their invention to the world . Hopefullly Next time is vaccine from them US will confrim push the vaccine out , bcos trump want to be re-elected . But how welll is this vaccine , duuno . SG gov wun use to us until is totally proven .
Useful To Me  Not Useful To Me
Luke1923 Senior	15-Jul-2020 14:39        Luke1923 About Contact  Quote this Post! Style: Combined   Mood: Yells: "The Lord is my Shepherd; I shall not want."
x 0   x 0  Alert Admin	1) It was mentioned in the Announcement that the Company had, on 9 July 2020, entered into a licensing agreement (the " Agreement" ) with Accelerate Technologies Pte Ltd (A*ccelerate) for a duration of five years from the date of the Agreement (the Term). Did the Company provide any consideration or outlay for being granted the non-exclusive worldwide rights to use the Technology for the detection of COVID-19 viral spike/Angiotensin Converting Enzyme 2 ( ACES ) blocking antibodies? 2) What are the rights assignment for the products or technologies that are subsequently developed by the Company using the Technology? Are there any differences between how these rights are assigned during the Term and after the Term? Does Biolidics have exclusive rights to the said products or technologies?  3) It is stated in the Announcement that the Company will further develop the Technology .  (a) What is the current status and the Company' s ability with regards to its efforts to further develop the Technology ?  (b) At present, what is the projected timeline or milestone, if any, for Biolidics to successfully develop the Technology?  (c) Are there any conditions that need to be met, such as the completion of the Technology development by the Company, before it could market the serology tests which incorporate the Technology into its Covid-19 Antibody Test Kit or into any other form of serology tests? (d) When does the Company expect to be able to market the serology tests which incorporate the Technology into its Covid-19 Antibody Test Kit or into any other form of serology tests? 4) At present, how far along is Biolidics in successfully incorporating the Technology into its Covid-19 Antibody Test Kit, or into any other form of serology tests? 5) The Agreement with A*ccelerate was entered into on 9 July 2020. We note that the Company called for trading halt on 13 July 2020, at 12:19pm, and released the Announcement on 14 July 2020, 10:46pm.  (a) What are the reasons for the delay in the announcement .  (b) Was the Sponsor aware and consulted on the disclosure of this matter and what was their advice.  (c) When did the Board and Sponsor approve the announcement?
Useful To Me  Not Useful To Me
wolverine23 Supreme	15-Jul-2020 14:26        wolverine23 About Contact  Quote this Post! Style: Flexible   Mood: Yells: "Medical Bull 2020 !!!!!!!! = Internet Bull 2000 !!!!!!!!"
x 0   x 0  Alert Admin	Don't assume one is right unless proven. Anything can happen! WL123456      ( Date: 15-Jul-2020 14:04) Posted: It?s a pity that people don?t learn their lesson. What you post if very useful but still people don?t look at fundamentals and wants to join in the pump and dump. They didn?t realise that this company has been releasing such info periodically just to ramp up the share price but in the end, the company still record losses. However I applaud your ethics in reaching out to those newbies who would have otherwise be caught in the euphoria. Starship      ( Date: 15-Jul-2020 13:52) Posted: Prof Mak has been spot on in every company that he wrote about. It' s clear as day that nearly all posters here are punters/day-traders/momentum traders. And the companies that Prof Mak has written abt are all exactly the kind of companies that such " investors" loved and lost their pants when their bubbles burst. Go look at his site. https://governanceforstakeholders.com Mak Yuen Teen is Associate Professor of Accounting at the NUS Business School. He founded the Corporate Governance and Financial Reporting Centre (CGFRC) at the NUS Business School, National University of Singapore in January 2003, and retired as director of the centre in December 2009. He was Vice Dean (Finance and Administration) at the school from 2002 to 2004. Professor Mak holds First Class Honours, Masters and PhD degrees in accounting and finance, and is a fellow of CPA Australia. He has held Asia-Pacific and Singapore heads of research positions at major consulting firms while on leave from the university. Professor Mak was a member of the Corporate Governance Committee which released Singapore&rsquo s first Code of Corporate Governance for listed companies, the Council on Corporate Disclosure and Governance (CCDG) which prescribed accounting standards and revised the Code in 2005, and the Corporate Governance Council which released the fourth version of the Code in 2018. He is currently a member of the Corporate Governance Advisory Committee set up the Monetary Authority of Singapore. He was a member of the Charity Council in Singapore from its establishment in October 2006 until his retirement in 2013. During his term, he chaired the subcommittees which developed and revised the code of governance for charities. He was also a member of the advisory panel set up by the Ministry of National Development for the development of a code of governance for town councils in Singapore. Professor Mak was a member of the audit advisory committee of the United Nations Population Fund based in New York from its establishment in October 2006 and retired in 2013. He then served as a member of the audit advisory committee of UN Women until October 2018. He was also an honorary advisor for BoardAgender, an organisation under the Singapore Council of Women Organisations in Singapore set up to promote gender diversity on boards and senior management, during its establishment phase. He has chaired a large healthcare charity and has served on boards and committees of other not-for-profit organisations. Professor Mak teaches corporate governance at NUS and conducts training for regulators, directors and other professsionals in corporate governance. He has consulted for local and international companies, regulators, and international intergovernmental organisations. He speaks regularly in conferences in Singapore and in the region, and is a regular commentator on corporate governance issues in the local and regional media. Professor Mak developed the Governance and Transparency Index (GTI) covering all listed companies in Singapore, which was published by the Business Times, sponsored by CPA Australia. He was the Singapore expert in the development of the ASEAN Corporate Governance Scorecard and Ranking project, an initiative of the ASEAN regulators to raise corporate governance standards amongst large ASEAN companies, and was involved in the ranking exercises for the first two years. In 2017, he also launched the Governance Index for Trusts (GIFT) which he co-developed, which is the only index published in Singapore which is designed specifically for REITs and business trusts. He was chair of the Singapore Corporate Governance Awards from 2003 to 2009 and chaired the Investor Relations Award under the Singapore Corporate Awards from its inception until 2014. His report on improving the implementation of corporate governance practices in Singapore, commissioned by the Monetary Authority of Singapore and Singapore Exchange, was published in June 2007 and several of his recommendations have been implemented. His book &ldquo From Conformance to Performance: Best Corporate Governance Practices for Asian companies&rdquo was published by McGraw-Hill in 2005. In 2012, he published a primer on governance for social enterprises commissioned by the Social Enterprise Association in 2012, and a guide for nominating committees of listed companies. Since 2012, he has edited an annual collection of Asian and international corporate governance case studies published and sponsored by CPA Australia. Selected cases and volumes have been translated to Chinese and Vietnamese. He led a research project on board diversity in Asia Pacific, commissioned by Korn/Ferry International. He was the consultant for a project commissioned by the Diversity Task Force (established by the Ministry of Social and Family Development in Singapore) which led to a number of recommendations on improving gender diversity on boards of Singapore listed companies, which are now being implemented by the Diversity Action Committee. He has also published papers on corporate governance and accounting in academic journals such as the Journal of Corporate Finance and Journal of Accounting and Public Policy, as well as practice-oriented journals. In 2014, the received the Corporate Governance Excellence Award from the Securities Investors Association (Singapore) for his contributions to improving corporate governance in Singapore. In 2015, he received the Recognition Award from the Minority Shareholders Watchdog Group as part of their Malaysian Corporate Governance Index-ASEAN CG Scorecard Awards for his contributions to raising corporate governance standards in the region. That same year, he was recognised by the Singapore Institute of Directors and a CG pioneer.
Useful To Me  Not Useful To Me
Starship Supreme	15-Jul-2020 14:25        Starship About Contact  Quote this Post!
x 0   x 0  Alert Admin	What u said below also describes YuuZOO during it' s heyday when tons of traders/punters/gamblers all piled in together with tons of cheerleaders. And then Prof Mak came along. And then the bubble burst. https://deanndjy355.hatenablog.com   Laurenpanna      ( Date: 15-Jul-2020 14:07) Posted: I realise this Prof likes to pick on every news that Biolidics published. I am not sure why. I still have confidence in this company because i see the Boss been working hard to get deals. I like the fact that he donated to Mongolia when we are not even sure if he is making money (Maybe he did, that is why he is able to donate, but figures are not out yet we can' t judge) I would give the stock some time.. since i have come so far..... everyday is an excitement altho at times, there are small disappointments too. But i would love to see the company grow.
Useful To Me  Not Useful To Me

                                                         First   < Newer   1581-1600 of 4174   Older>   Last